ACTION Registry-GWTG Results: January 1, 2009 – December 31, 2009.
Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately.
